Form 4 Filing: LEDERMAN SETH Buys $59K of $TNXP

INSIDER PURCHASE

⚡ MATERIALITY: 7/10

corporate issuer

Tonix Pharmaceuticals Holding Corp.

Ticker: $TNXP

Transaction Value

$59K

Price/Share: $11.79

transaction date

2026-06-09

Shares: 5,000

Market Price Activity

HillSignal AI Analytical Report

SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, LEDERMAN SETH, holds the title of Chief Executive Officer at Tonix Pharmaceuticals Holding Corp..

On 2026-06-09, the insider transacted 5,000 shares.The shares were transacted at a weighted average price of $11.79 per share, resulting in a total market-relevant value of $59K.

Executive Summary Summary

LEDERMAN SETH (Chief Executive Officer) bought $59K of $TNXP

Post-Transaction Position: 9,005 shares

SEC Accession No: 0001493152-26-027986 (CIK: 1563420)

Verified Multi-Source Index

Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.

SEC EDGAR FilingView Source Form 4

Yahoo Finance$TNXP Quote & Profile

OpenCorporates RegistryVerify Corporate Identity

Google News$TNXP News Coverage